Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toronto Dominion Bank
TD
|
+$400M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$314M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$300M |
| 4 |
Manulife Financial
MFC
|
+$296M |
| 5 |
TJX Companies
TJX
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$321M |
| 2 |
FRC
First Republic Bank
FRC
|
+$208M |
| 3 |
Intel
INTC
|
+$180M |
| 4 |
Willis Towers Watson
WTW
|
+$168M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.69% |
| 2 | Technology | 13.43% |
| 3 | Healthcare | 7.83% |
| 4 | Communication Services | 7.82% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Madrigal Pharmaceuticals
MDGL
$11.7B
| $629K | ﹤0.01% |
7,873
+174
| +2% | +$15K |
|
4077
Mine Safety
MSA
$7.3B
| $628K | ﹤0.01% |
4,311
-1,052
| -20% | -$167K |
|
|
BRCN
4078
DELISTED
Burcon NutraScience Corporation
BRCN
| $628K | ﹤0.01% |
402,098
-61,650
| -13% | -$144K |
|
4079
Avantis International Small Cap Value ETF
AVDV
$20B
| $627K | ﹤0.01% |
9,696
-20,662
| -68% | -$1.35M |
|
4080
Invesco Pharmaceuticals ETF
PJP
$500M
| $627K | ﹤0.01% |
8,105
-1,854
| -19% | -$149K |
|
|
HOOK
4081
DELISTED
HOOKIPA Pharma
HOOK
| $626K | ﹤0.01% |
10,639
+7,053
| +197% | +$511K |
|
|
ECF
4082
Ellsworth Growth & Income Fund
ECF
$177M
| $624K | ﹤0.01% |
46,708
+2,209
| +5% | +$32.1K |
|
4083
iShares MSCI Thailand ETF
THD
$353M
| $624K | ﹤0.01% |
8,362
+3,515
| +73% | +$265K |
|
4084
Codexis
CDXS
$171M
| $623K | ﹤0.01% |
26,781
+1,986
| +8% | +$47K |
|
|
IMVP
4085
Invesco India ETF
IMVP
$107M
| $623K | ﹤0.01% |
21,847
-11,491
| -34% | -$313K |
|
4086
Climb Global Solutions
CLMB
$532M
| $622K | ﹤0.01% |
92,400
+67,600
| +273% | +$459K |
|
4087
Evolent Health
EVH
$529M
| $621K | ﹤0.01% |
20,039
+2,134
| +12% | +$51.2K |
|
|
CPARU
4088
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $621K | ﹤0.01% |
63,065
+6,692
| +12% | +$66.6K |
|
|
CDK
4089
DELISTED
CDK Global, Inc.
CDK
| $621K | ﹤0.01% |
14,591
-129,291
| -90% | -$5.83M |
|
4090
Arbutus Biopharma
ABUS
$924M
| $620K | ﹤0.01% |
144,437
+85,542
| +145% | +$285K |
|
|
HTLF
4091
DELISTED
Heartland Financial USA, Inc.
HTLF
| $620K | ﹤0.01% |
12,919
+2,212
| +21% | +$103K |
|
|
JTA
4092
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
| $620K | ﹤0.01% |
55,900
-1,324
| -2% | -$15.2K |
|
4093
Grupo Aeroportuario del Sureste
ASR
$7.94B
| $619K | ﹤0.01% |
3,312
-247
| -7% | -$44.6K |
|
4094
Autohome
ATHM
$2.61B
| $619K | ﹤0.01% |
13,183
+351
| +3% | +$16.6K |
|
|
MUE
4095
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
| $618K | ﹤0.01% |
44,729
+2,113
| +5% | +$30.5K |
|
4096
Viemed Healthcare
VMD
$350M
| $618K | ﹤0.01% |
111,489
-775
| -0.7% | -$5.04K |
|
4097
Hawkins
HWKN
$2.74B
| $617K | ﹤0.01% |
17,695
+378
| +2% | +$13.1K |
|
4098
Townsquare Media
TSQ
$104M
| $617K | ﹤0.01% |
47,250
-700
| -1% | -$8.84K |
|
|
RPT
4099
Rithm Property Trust
RPT
$104M
| $617K | ﹤0.01% |
7,616
+186
| +3% | +$14.9K |
|
|
EQC
4100
DELISTED
Equity Commonwealth
EQC
| $615K | ﹤0.01% |
23,635
-8,194
| -26% | -$216K |
|
Similar funds
Royal Bank of Canada's Q3 2021 Portfolio in Review
As of Q3 2021, Royal Bank of Canada held 8,227 positions worth $379B, up 0.88% from $376B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q3 2021 filing shows 602 new, 3,872 increased, 2,499 reduced and 487 closed positions. Its largest new stake was Victoria's Secret: 378,616 shares worth $20.9M. The largest sale was Alphabet (Google) Class C, an estimated $321M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
- Royal Bank of Canada's largest Q3 2021 buy was Victoria's Secret: 378,616 shares worth $20.9M.
- Royal Bank of Canada added most to Toronto Dominion Bank in Q3 2021, an estimated $400M increase.
- Royal Bank of Canada's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $321M.
- Royal Bank of Canada fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $153M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $379B portfolio in Q3 2021.
- Royal Bank of Canada opened 602 new positions and closed 487 in Q3 2021.
- Royal Bank of Canada's portfolio value rose 0.88% quarter-over-quarter to $379B.
Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.